Market Overview

US Stock Futures Surge Ahead Of Housing-Starts Data

US Stock Futures Surge Ahead Of Housing-Starts Data
Related HD
Home Retailers Are Getting Crushed After Sears Partners With Amazon
Nordstrom Given Strong Sell Rating By Vetr Crowd
Gilbert & Cook, Inc. Buys Schwab U.S. ... (GuruFocus)
Related AAPL
If The iPhone 8 Is Delayed, Will Anyone Care?
Contract Manufacturers Are Joining Apple's Side As Qualcomm Legal Concerns Continue
These 4 Technology ETFs Are Near Buy Points As Sector Remains Hot (Investor's Business Daily)

Pre-open movers

US stock futures traded higher in early pre-market trade. Data on housing starts for April will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average jumped 52 points to 18,311.00, while the Standard & Poor's 500 index futures rose 5.45 points to 2,131.45. Futures for the Nasdaq 100 index climbed 15.95 points to 4,523.20.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index rising 1.35 percent, STOXX Europe 600 Index gaining 1.18 percent and German DAX 30 index rising 1.71 percent. French CAC 40 Index climbed 1.69 percent and London's FTSE 100 Index fell 0.31 percent.

In Asian markets, Japan's Nikkei Stock Average rose 0.68 percent, China's Shanghai Composite Index climbed 3.13 percent, Hong Kong's Hang Seng Index gained 0.37 percent and India's BSE Sensex slipped 0.15 percent.

Broker Recommendation
Analysts at Oppenheimer downgraded Urban Outfitters, Inc. (NASDAQ: URBN) from Outperform to Market Perform and lowered the price target from $44.00 to $35.00.

Urban Outfitters shares dipped 15.42 percent to $34.44 in pre-market trading.

Breaking news

  • Home Depot Inc (NYSE: HD) reported better-than-expected earnings for the first quarter and raised its forecast for the full year. To read the full news, click here.
  • TomTom has renewed and extended its global agreement with Apple Inc. (NASDAQ: AAPL) for maps and related information. To read the full news, click here.
  • Oncolytics Biotech Inc. (NASDAQ: ONCY) today announced that following submission to the U.S. Food and Drug Administration for review, the Investigational New Drug Application containing the protocol titled "MC1472: Phase 1 Study of Replication Competent Reovirus (REOLYSIN®) in Combination with GM-CSF in Pediatric Patients with Relapsed or Refractory Brain Tumors" is now active. To read the full news, click here.
  • M.D.C. Holdings, Inc. (NYSE: MDC) today announced that the Company's current Chief Financial Officer, John M. Stephens, is resigning effective May 22, 2015. Mr. Stephens has served as Chief Financial Officer since February 2012. To read the full news, click here.

Posted-In: Oppenheimer US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AAPL + HD)

View Comments and Join the Discussion!